Azienda Sanitaria Locale Roma 4
- Address
- Largo Donatori Di Sangue 1, 00053 Civitavecchia, Italy
Azienda Sanitaria Locale Roma 4 - Oncology and Pain Management Research
Azienda Sanitaria Locale Roma 4 is a clinical research facility engaged in advancing therapeutic approaches across multiple medical specialties. The center demonstrates particular expertise in oncology research with a focus on precision medicine approaches for lung cancer, as well as investigations into novel analgesic treatments for chronic pain management.
- Advanced non-small-cell lung cancer (NSCLC) with targeted therapies including immunotherapy and EGFR-TKI sequencing strategies
- Precision oncology investigating optimal treatment sequences for EGFR mutation-positive metastatic lung cancer
- Chronic pain management with focus on novel analgesic formulations for low back pain
The center's oncology research portfolio emphasizes biomarker-driven treatment strategies, including studies evaluating immunotherapy combinations in PD-L1 high populations and optimizing EGFR tyrosine kinase inhibitor sequencing in patients with classical and uncommon EGFR mutations. Their pain management research explores innovative analgesic formulations compared to standard treatments, contributing to evidence-based approaches for chronic musculoskeletal conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Fondazione Ricerca Traslazionale2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Fondazione Ricerca Traslazionale2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Azienda Sanitaria Locale Roma 4
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study | Horizon Therapeutics Ireland Designated Activity Company | Phase III | Not Recruiting | Jun 2024 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Atezolizumab | 1 | Unknown | 2020-01-31 | 2020-01-31 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.